So he took his a fraction of his 10% divined, and bought

New Post Public Reply Private Reply Replies (0) Message Board
trding the lawman #10365
506
So he took his a fraction of his 10% divined, and bought shares and that is impressive?

You will never convince me about NP's lack of investment here. He has half his salary deferred in stock options, his credibility and life's work is tied up into getting leronlimab to the finish line. He is fully invested!

Now, I'm surprised on a day that NP missed a miss big deadline you would focus on this. Surely you would have a better argument focusing on NP's performance and not questioning NP's investment or if he believes in the company. He is putting his own mother-in-law with stage 4 cancer on leronlimab for pete's sake; her life is literally on the line. You don't think he believes in leronlimab or cydy?

Here is a better argument for you:

golden quarter
no more fund raising after the TO
deal in two weeks
BLA by end of September
financing with paulson, selling shares risk free warrants
convertible financing with fife
R/S announced then canceled after realizing raising cash terms too high

Say all that, then say, if he misses the BLA timeline by end of year and the deal doesn't get done, then he should be replaced. You will get lots of support. Beating the dead horse no investment isn't going to get you anywhere.


My opinion:

Are there better CEOs? yeah. Are there better CEOs on OTC? rare
Will he be replaced? No, never on otc.
Why I don't focus on NP? Wasted cause. Wasted effort. I don't invest in companies I think would be great if the CEO was replaced. I look to see if the current CEO can get it done. Will all his flaws, I think he gets us to approval or I wouldn't be here. Once the company doesn't need to sell shares to continue and can use revenue, it will be a game changer. I see lots of pre-revenue biotech, nasdaq even, tanking worse than cydy over time. Getting drug approval changes that and we are inching closer and closer to the finish line, I'm betting NP gets us there. Again, if I thought it would take another ceo to gets us there, I would be gone.


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 5

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 10

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 9

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rambus Insider Sale Signals Strategic Shifts and Insights

Updated Category News Views 136

Rambus Insider Trading Activities In a noteworthy development, John Shinn, the Senior Vice President at Rambus, has made headlines by selling 790 shares of the company, as indicated in a recent SEC filing. This transaction, valued at approximately $58,944, has caught the attention of investors and analysts alike. While insiders frequently buy or sell shares based on...

Continue Reading
Helios Fairfax Partners Reports Q4 and 2024 Year-End Results

Updated Category News Views 437

Overview of Financial Performance Helios Fairfax Partners Corporation (TSX: HFPC.U) has shared its financial performance for the fourth quarter and the entire year ending in 2024. This report outlines the financial outcomes while keeping stakeholders informed about the company's strategic investments. Management Insights Co-CEOs Tope Lawani and Babatunde Soyoye commented...

Continue Reading
Comparative Insights on Waymo’s Lead Over Tesla in Autonomy

Updated Category News Views 97

Waymo's Dominance in the Robotaxi Market In a recent analysis, tech analyst Gene Munster emphasized that Waymo, backed by Alphabet Inc. (NASDAQ: GOOG), is significantly outperforming Tesla Inc. (NASDAQ: TSLA) in the competitive robotaxi landscape. He metaphorically illustrated the scenario by saying, "If this were a basketball game, Waymo would lead 50-2," highlighting...

Continue Reading
Report on Recent Transactions by Danske Bank Executives

Updated Category News Views 149

Insights into Danske Bank A/S Management Transactions Danske Bank A/S has been actively engaging in transactions by its managerial personnel, as mandated by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen under the European Union's Market Abuse Regulation. These regulations ensure transparency and maintain investor confidence. Share Buy-Back Program...

Continue Reading
Volkswagen Faces Major Restructuring Amid Job Losses in Germany

Updated Category News Views 275

Volkswagen's Challenge in Restructuring Volkswagen is navigating a pivotal moment as it prepares to implement significant changes in Germany that could lead to the shutdown of at least three factories and the potential layoff of tens of thousands of employees. These adjustments are a response to the need for a deeper overhaul, marked by rising costs and productivity...

Continue Reading